Search Results - "Ugen, Kenneth"

Refine Results
  1. 1
  2. 2
  3. 3

    Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma by DAUD, Adil I, DECONTI, Ronald C, HELLER, Richard, ANDREWS, Stephanie, URBAS, Patricia, RIKER, Adam I, SONDAK, Vernon K, MUNSTER, Pamela N, SULLIVAN, Daniel M, UGEN, Kenneth E, MESSINA, Jane L

    Published in Journal of clinical oncology (20-12-2008)
    “…Gene-based immunotherapy for cancer is limited by the lack of safe, efficient, reproducible, and titratable delivery methods. Direct injection of DNA into…”
    Get full text
    Journal Article
  4. 4

    A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus by Choi, Hyeree, Kudchodkar, Sagar B, Ho, Michelle, Reuschel, Emma L, Reynolds, Erin, Xu, Ziyang, Bordoloi, Devivasha, Ugen, Kenneth E, Tebas, Pablo, Kim, Joseph, Abdel-Mohsen, Mohamed, Thangamani, Saravanan, Weiner, David B, Muthumani, Kar

    Published in PLoS neglected tropical diseases (01-10-2020)
    “…Powassan virus (POWV) infection is a tick-borne emerging infectious disease in the United States and North America. Like Zika virus, POWV is a member of the…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody by Zankharia, Urvi S., Kudchodkar, Sagar, Khoshnejad, Makan, Perales-Puchalt, Alfredo, Choi, Hyeree, Ho, Michelle, Zaidi, Faraz, Ugen, Kenneth E., Kim, Joseph J., Weiner, David B., Muthumani, Kar

    Published in Human vaccines & immunotherapeutics (01-09-2020)
    “…Hepatitis B virus (HBV) causes a potentially life-threatening liver infection that frequently results in life-long chronic infection. HBV is responsible for…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab by Muthumani, Kar, Flingai, Seleeke, Wise, Megan, Tingey, Colleen, Ugen, Kenneth E, Weiner, David B

    Published in Human vaccines & immunotherapeutics (01-10-2013)
    “…Monoclonal antibody preparations have demonstrated considerable clinical utility in the treatment of specific malignancies, as well as inflammatory and…”
    Get full text
    Journal Article
  10. 10

    Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease by Ugen, Kenneth E, Lin, Xiaoyang, Bai, Ge, Liang, Zhanhua, Cai, Jianfeng, Li, Kunyun, Song, Shijie, Cao, Chuanhai, Sanchez-Ramos, Juan

    Published in Human vaccines & immunotherapeutics (03-04-2015)
    “…In order to develop a cell-based vaccine against the Parkinson disease (PD) associated protein α-synuclein (α-Syn) 3 peptides were synthesized based upon…”
    Get full text
    Journal Article
  11. 11

    Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease by Morgan, Dave, Diamond, David M, Gottschall, Paul E, Ugen, Kenneth E, Dickey, Chad, Hardy, John, Duff, Karen, Jantzen, Paul, DiCarlo, Giovanni, Wilcock, Donna, Connor, Karen, Hatcher, Jaime, Hope, Caroline, Gordon, Marcia, Arendash, Gary W

    Published in Nature (London) (21-12-2000)
    “…Vaccinations with amyloid-β peptide (AB) can dramatically reduce amyloid deposition in a transgenic mouse model of Alzheimer's disease. To determine if the…”
    Get full text
    Journal Article
  12. 12

    Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration by Wilcock, Donna M, Munireddy, Sanjay K, Rosenthal, Arnon, Ugen, Kenneth E, Gordon, Marcia N, Morgan, Dave

    Published in Neurobiology of disease (01-02-2004)
    “…The mechanisms by which anti-Aβ antibodies clear amyloid plaques in Aβ depositing transgenic mice are unclear. In the current study, we demonstrate that…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations by Kudrna, Jeremy J, Ugen, Kenneth E

    Published in Human vaccines & immunotherapeutics (03-08-2015)
    “…There has been a recent expansion of vaccination and immunotherapeutic strategies from controlling infectious diseases to the targeting of non-infectious…”
    Get full text
    Journal Article
  15. 15

    Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Aβ antibodies by Li, Qingyou, Gordon, Marcia, Cao, Chuanhai, Ugen, Kenneth E, Morgan, Dave

    Published in BMC neuroscience (20-03-2007)
    “…Abstract Background Prior work from our group found that acid dissociation (pH 2.5 incubation) of serum from APP transgenic mice vaccinated against Aβ…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Protocols for Developing Novel Chikungunya Virus DNA Vaccines by Chung, Christopher, Ugen, Kenneth E, Sardesai, Niranjan Y, Weiner, David B, Muthumani, Kar

    “…To date, there have been several million infections by the Chikungunya virus (CHIKV), a mosquito-transmitted emerging pathogen that is considered to be…”
    Get more information
    Journal Article
  18. 18

    DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade by GIRI, Malavika, UGEN, Kenneth E, WEINER, David B

    Published in Clinical Microbiology Reviews (01-04-2004)
    “…Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19
  20. 20